Patent · US Active

Implants using ultrasonic communication for modulating splenic nerve activity

US11890474B2 · kind B2 · utility

4Cited by
81References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 19, 2019
Grant dateFeb 6, 2024
Priority date
Expiry dateApr 19, 2039

Classification

  • Technology area (CPC H)Electricity
  • CPC primaryH02J2310/23
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Described herein are methods for monitoring or modulating an immune system in a subject; treating, reducing or monitoring inflammation; monitoring blood pressure; treating hypertension; or administering or adjusting a therapy for inflammation or hypertension in a patient by electrically stimulating the splenic nerve or detecting splenic nerve activity using an implanted medical device. Also described herein are implantable medical devices for performing such methods. The implanted medical device includes an ultrasonic transducer configured to receive ultrasonic waves and convert energy from the ultrasonic waves into an electrical energy that powers the device, two or more electrodes in electrical communication with the ultrasonic transducer that are configured to electrically stimulate a splenic nerve or detect a splenic nerve activity, and optionally a splenic nerve attachment member.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.